# Publisher Phase 3-10 Release Notes

Date: 2026-07-30

## Scope

Phase 3-10 finalizes release gate status after Phase 3-9 release readiness
evidence was recorded. This phase does not approve the release, create tags,
publish artifacts, execute Live E2E, or change production behavior.

The Phase 3-9 package release approval remains pending external vendor response
because the Avast false positive submission is awaiting classification.

## Release Gate Status

- Phase 3-9 release readiness evidence remains recorded in
  `docs/distribution/ReleaseChecklist.md`.
- Final release approval is pending Avast response or explicit repository-owner
  acceptance of the antivirus exception posture.
- The package must not be treated as production-approved while this dependency
  remains open.
- Release tags, public distribution, release announcement, and Live E2E remain
  out of scope without explicit authorization.

## Pending Risk Management

The pending Avast response is tracked as an external release-approval
dependency, not as a Publisher implementation defect confirmed by local
evidence. Existing local evidence recorded in the checklist includes package
verification, matching hashes, configuration exclusion, and no VirusTotal
detection at the time of the Phase 3-9 readiness pass.

Closure requires one of the outcomes recorded in the Phase 3-10 section of
`docs/distribution/ReleaseChecklist.md`.

## Phase 4 Entry Conditions

Phase 4 may proceed only as non-release work while the Avast dependency remains
pending. Starting Phase 4 must not imply approval of the Phase 3-9 package.

Phase 4 work must preserve Frozen specifications, public APIs, persisted
schemas, canonical formats, production defaults, package artifacts, and release
state unless a separate explicit authorization is given. Any change to the
package trust posture, signing model, installer model, or production release
process must be isolated as a vNext candidate before adoption.
